Europe Cold Plasma Equipment Market to Grow at a CAGR of 15.1% to reach US$ 72.57 million from 2019 to 2027

The Europe cold plasma equipment market is expected to reach US$ 72.57 Mn in 2027 from US$ 23.73 Mn in 2019. The market is estimated to grow with a CAGR of 15.1% from 2019-2027.

The growth of the market is driven by factors such as the rising use of cold plasma in medical treatment, increasing hospital acquired infections (HAI) and others in the European region. Whereas, adverse effects of cold plasma, and lack of reimbursement are likely to have a negative impact on the growth of the market in the coming years.

Cold Plasma is also called as non-thermal plasma and used in wide range of applications in various industries including medical and biomedical industries. It is a powerful tool which is used to provide antimicrobial treatment for wounds and injuries. The Cold Plasma Equipment technology offers non-thermal treatment of cancer, dentistry and others.

Cold plasma is proved very effective in the biomedicine. Cold plasma is used in many medical treatments such as, wound healing, cancer, dermatology, atmospheric plasma on diabetes-induced enzyme glycation, oxidative stress, and inflammation, disinfection and scar treatment. Cold plasma's ability to kill bacteria, including the drug-resistant bacteria, to avoid further infection, helps in chronic wounds. This accelerates the process of wound healing and prevents further complications and the related discomforts. Although there are many other treatment methods for wound healing, it is expected that cold plasma therapy is one of the most effective ways. Plasma sources used in plasma medicine are typically "low temperature" plasma sources operated at atmospheric pressure. In this context, low temperature refers to temperatures similar to room temperature, usually slightly above. Increasing in cases of diabetes, wound and other inflammation, is growing the market.

Diabetes affects many parts of the body, especially feet. Diabetic foot ulcers are sores that develop on the feet, and they can develop even from seemingly trivial injuries to the feet. Diabetic foot ulcers are a common cause of amputation due to diabetes. According to WHO/Europe, there are about 60 million people with diabetes in the European Region or approximately 10.3% of men and 9.6% of women aged 25 years and over. The prevalence of diabetes is increasing among all ages in the European Region, mostly due to increases in overweight and obesity, unhealthy diet, and physical inactivity. Due to a rise in the use of cold plasma, in various kinds of treatment, it is likely to increase the cold plasma equipment market. Therefore, the demand for cold plasma equipment is expected to increase during the forecast period.

The increasing use of cold plasma equipment in medical treatment cases in Europe is expected to drive cold plasma equipment market the growing pharmaceutical industry in the country create a lucrative opportunity and the presence of an established market for cold plasma equipment.

Rest of Europe Cold plasma equipment Market Revenue and Forecasts to 2027 (US$ Bn)

EUROPE COLD PLASMA EQUIPMENT– MARKET SEGMENTATION

Europe Cold Plasma Equipment Market - By Regime

• Atmospheric Cold Plasma Equipment
• Low Pressure Cold Plasma Equipment

Europe Cold Plasma Equipment Market - By Application

• Wound Healing
• Blood Coagulation
• Cancer Treatment
• Dentistry
• Other Applications

Europe Cold Plasma Equipment Market - By Country

• Germany
• UK
• France
• Italy
• Spain

Companies Mentioned

• Henniker Plasma
• Nordson Corporation
• TheraDep Technologies
• Neoplas tools GmbH
• Plasmatreat GmbH
• Adtec.
• terraplasma medical GmbH
• Tantec A/S
• Europlasma NV
• Bovie Medical

Europe Cold Plasma Equipment Report Scope